Video | Why Lipid Lowering Agents are
Familial Chylomicronemia Syndrome
Home
About FCS
Signs and Symptoms
Diet Considerations
Non-Dietary
Treatment Options
Resources
FCS Video Library

Why Lipid Lowering Agents are Ineffective in FCS

Since patients with familial chylomicronemia syndrome (FCS) are missing the enzyme (lipoprotein lipase) necessary to remove triglycerides and standard lipid lowering agents require that enzyme to be effective, most of those agents do not work for patients with FCS.

FCS is a rare genetic disorder in which children and adults have extremely high triglycerides and chylomicrons.

Daniel Rader, M.D., Perelman School of Medicine, University of Pennsylvania, Philadelphia PA is a leading authority in the management of FCS.

Related FCS Videos

An introduction to FCS
Natural History of FCS
The Genetics of FCS
Suspecting FCS in Children
Signs and Symptoms of FCS
Young Adults and FCS
The FCS Diet
Why a Low Fat Diet is Necessary
FCS Patient Registry
Management of FCS is a
Team Effort
Low Fat Diet and FCS
FCS Triggers
The Long Term Outlook for Patients with FCS
Diagnosing FCS
Milky Blood Samples with FCS
Pancreatitis and FCS
Content funded by Novartis Pharmaceuticals Corporation and developed in collaboration with Rare Disease Report. All material on this website protected by copyright, Copyright 2014 Rare Disease Report.
About RareDR
Terms and Conditions
RareDR
HCPLive®